AngioDynamics announced that it has formed a new partnership with Minimax Medical for international distribution of their product portfolio.
The new distribution arrangement with Minimax Medical becomes effective 15 November 2022. The partnership will include the distribution of Minimax Medical’s leading Radiofrequency Ablation System for tumors / nodules on an international level.
“I am delighted that this new partnership has come together in order to provide a greater range of solutions to clinicians and their patients. Working together with Minimax Medical will only enhance AngioDynamics’ ability to support the healthcare sector in improving patients’ lives across the globe” said Laura Piccinini, AngioDynamics Senior Vice President/General Manager – International.
Minimax Medical, provides some of the most transformative RFA devices available on the market.
Anna Li, Minimax Medical’s President, said “Minimax and AngioDynamics have been partners for more than 18 years in the tumor ablation market, this new strategic cooperation has strengthened this partnership. I believe together we will be stronger and we shall prevail.”
About Minimax Medical.
“Minimax Medical Holding Group is an international medical science and technology group founded in 2003, providing minimally invasive devices that cover various fields, including interventional oncology, vascular intervention, minimally invasive treatment for hemorrhoids, surgical treatment, etc. Their corporate vision is to provide medical science and technology that improve quality of life. In that connection, they have been providing effective treatments which cause less injuries and relieve patients from pain, through integrating global advanced medical technology with their products.”
Website of Minimax Medical: http://www.minimaxmed.com.